ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,793.30
1.44%
S&P ASX All Technology
3,068.10
1.62%
Brent Oil
83.105
-0.44%
US Dollar vs AUD
1.51717
0.49%
Bitcoin
62,841.56
-0.51%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Decision Diagnostics Corporation (CE) (DECN)

  7. Decision Diagnostics Corporation (CE) (DECN) News

DECN

Decision Diagnostics (CE) (DECN)

Decision Diagnostics Corporation (CE)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:DECN
DateTimeSourceHeadlineSymbolCompany
06/07/202023:16InvestorsHub NewsWireThe Rapid Rise of Alternet Systems, Inc. (OTCMKTS: ALYI)USOTC:DECNDecision Diagnostics Corporation (CE)
05/03/202002:15InvestorsHub NewsWireDECN Fills in the Gaps, Adds to Knowledge Base for its GenViro Coronavirus (Covid19) Multi-Dimensional Diagnostic MethodologyUSOTC:DECNDecision Diagnostics Corporation (CE)
09/05/201923:55InvestorsHub NewsWireDECN SETS PLAN TO MAKE UPCOMING PATENT APPEAL HEARING AND MEDIATION WITH JOHNSON & JOHNSON A FOUNDATION FOR SUBSTANTIAL RECOV...USOTC:DECNDecision Diagnostics Corporation (CE)
05/04/201901:00InvestorsHub NewsWireDECN HAILS COMPLETION OF ITS GENULTIMATE! TBG PANACEA SYSTEM, 3RD PARTY TESTING TO BEGIN IN 7 DAYS, CLINICAL TRIALS IN MAYUSOTC:DECNDecision Diagnostics Corporation (CE)
19/03/201907:35Edgar (US Regulatory)Withdrawal of Offering Statement Under Regulation a (1-a-w)USOTC:DECNDecision Diagnostics Corporation (CE)
26/02/201907:34Edgar (US Regulatory)Amended Registration a Offering Under the Securities Act of 1933 (1-a/a)USOTC:DECNDecision Diagnostics Corporation (CE)
31/01/201902:00InvestorsHub NewsWireDECN SUBSIDIARY RECEIVES 510K SUBMISSION AND "K" NUMBERS FROM FDA CDRH FOR ITS GENCHOICE! TEST STRIP AT THE CLOSE OF THEUSOTC:DECNDecision Diagnostics Corporation (CE)
18/01/201901:55InvestorsHub NewsWireDECN DISCUSSES ITS GENULTIMATE! TBG SYSTEM, OFFERING ELITE PERFORMANCE AND PREMIER UPGRADE PATH FOR 4+ MILLION LIFESCAN USERSUSOTC:DECNDecision Diagnostics Corporation (CE)
20/12/201802:03InvestorsHub NewsWireDECN SUBSIDIARIES APPEAL NEVADA DISTRICT COURT RULING TO U.S. COURT OF APPEALS FOR THE FEDERAL CIRCUIT (the patent court)USOTC:DECNDecision Diagnostics Corporation (CE)
18/12/201801:55InvestorsHub NewsWireDECN ENGAGES SECOND KOREAN MANUFACTURING PARTNER TO RAISE ITS FACTORY CAPACITY TWO MILLION BOXES OF "GEN" TEST STRIPS ANNUALLYUSOTC:DECNDecision Diagnostics Corporation (CE)
12/12/201802:00InvestorsHub NewsWireDECN RELEASES ITS STRATEGIC IP AND PRODUCT DEVELOPMENT INTRODUCTION PLAN WITH A SUMMARY OF 2018 ACHIEVEMENTS & 2019 EXPECTATI...USOTC:DECNDecision Diagnostics Corporation (CE)
05/12/201802:00InvestorsHub NewsWireDECN RECEIVES CLINICAL TRIALS REPORT, ANTICIPATES FILING ITS FDA 510K APPLICATION FOR ITS GENCHOICE! TEST STRIP ON 12/21/2018USOTC:DECNDecision Diagnostics Corporation (CE)
28/11/201801:50InvestorsHub NewsWireDECN CEO KEITH M. BERMAN IS INTERVIEWED BY PRESTIGIOUS WALL STREET REPORTER WHO DESCRIBE COMPANY & PRODUCTS AS "GAME CHANGER"USOTC:DECNDecision Diagnostics Corporation (CE)
07/11/201801:55InvestorsHub NewsWireDECN RECEIVES COMPLETED CLINICAL TRIAL DATA, CHARTS AND SPREADSHEETS ESSENTIAL FOR ITS IMMINENT GENCHOICE! TEST STRIPUSOTC:DECNDecision Diagnostics Corporation (CE)
31/10/201800:33InvestorsHub NewsWireDECN SET TO APPEAL UNFAIR RULING IN COURT'S TERMINATION OF THE DECN CASE AGAINST INDUSTRY GIANT JOHNSON & JOHNSONUSOTC:DECNDecision Diagnostics Corporation (CE)
30/10/201801:15InvestorsHub NewsWireDECN TO COMMENT AND PROVIDE ATTACK PLAN AFTER RECENT COURT RULINGUSOTC:DECNDecision Diagnostics Corporation (CE)
14/09/201800:00InvestorsHub NewsWireDECN BOARD OF DIRECTORS IN FINAL REVIEW OF PRELIMINARY FINANCING AGREEMENT FOR $4.75 MILLION INVESTMENTUSOTC:DECNDecision Diagnostics Corporation (CE)
07/09/201800:00InvestorsHub NewsWireDECN ANNOUNCES MAJOR STEP AHEAD WITH OFFERING STATEMENTUSOTC:DECNDecision Diagnostics Corporation (CE)
01/08/201822:06Edgar (US Regulatory)Registration a Offering Under the Securities Act of 1933 (1-a)USOTC:DECNDecision Diagnostics Corporation (CE)
18/04/201823:51InvestorsHub NewsWireDecision Diagnostics (DECN) Contemplates Additional Legal Actions Against Longtime Adversary Johnson & Johnson (JNJ)USOTC:DECNDecision Diagnostics Corporation (CE)
28/03/201806:05InvestorsHub NewsWireDECISION DIAGNOSTICS DISCUSSES CULMINATION OF PATENT CASE AGAINST J&J BASED ON THE FEDERAL DOCTRINE OF EQUIVALENTSUSOTC:DECNDecision Diagnostics Corporation (CE)
22/03/201800:40InvestorsHub NewsWireDECISION DIAGNOSTICS' PANACEA GENPRECIS! PRODUCT MOVES INTO PRE-PRODUCTION, 1ST ROUND CLINICAL TRIALS TO BEGIN IN THE ~30 DAYSUSOTC:DECNDecision Diagnostics Corporation (CE)
14/03/201800:50InvestorsHub NewsWireDecision Diagnostics' Fundamental Genchoice! Test Strip Moves into Clinical Trials in Advance of 510K Filing with FDAUSOTC:DECNDecision Diagnostics Corporation (CE)
04/01/201801:55InvestorsHub NewsWireDECN ANNOUNCES 2018 BUSINESS FOCUS -- NEW PRODUCTS, CONCLUSION TO J&J LITIGATION & NEW ADDITION OF HYBRID PRIVATE LABEL MODELUSOTC:DECNDecision Diagnostics Corporation (CE)
21/12/201702:15InvestorsHub NewsWireDECISION DIAGNOSTICS PROVIDES ADDITIONAL COMMENTARY ABOUT ITS NEW GENACCORD!™, DIABETIC TEST STRIPUSOTC:DECNDecision Diagnostics Corporation (CE)
21/12/201702:15InvestorsHub NewsWireDECISION DIAGNOSTICS PROVIDES ADDITIONAL COMMENTARY ABOUT ITS NEW GENACCORD!™, DIABETIC TEST STRIPUSOTC:DECNDecision Diagnostics Corporation (CE)
21/12/201702:15InvestorsHub NewsWireDECISION DIAGNOSTICS PROVIDES ADDITIONAL COMMENTARY ABOUT ITS NEW GENACCORD!™, DIABETIC TEST STRIPUSOTC:DECNDecision Diagnostics Corporation (CE)
15/12/201702:00InvestorsHub NewsWireDECN ANNOUNCES IT'S NEW GENACCORD!™, DIABETIC TEST STRIP WITH FIRST USE OF ITS GENPRECIS!™ FULL SPREAD ELECTRODE ...USOTC:DECNDecision Diagnostics Corporation (CE)
02/11/201701:15InvestorsHub NewsWireDECISION DIAGNOSTICS CORP. (DECN) OFFERS UPDATE ON LEGAL PROCEEDINGS, OUTCOMES, HISTORY & SYNOPSIS ON ITS STRATEGIC SUIT VS. ...USOTC:DECNDecision Diagnostics Corporation (CE)
19/10/201701:10InvestorsHub NewsWireDECISION DIAGNOSTICS CORP FURTHER DISCUSSES ITS PANACEA GENPRECIS!™ PRODUCTUSOTC:DECNDecision Diagnostics Corporation (CE)
 Showing the most relevant articles for your search:USOTC:DECN

Your Recent History

ASX
SUN
Suncorp
SPI
SP500
S&P 500
NASDAQ
AMZN
Amazon.com
NYSE
NKE
Nike
NYSE
JPM
JP Morgan Chase
NYSE
VZ
Verizon Communications
ASX
XMM
S&P ASX 300 Metals and M...
COIN
ETHUSD
Ethereum
ASX
FMG
Fortescue
ASX
XAO
Australian SE All Ordina...
ASX
AMP
AMP
ASX
ANZ
Australia And New Zealan...
FX
GBPAUD
Sterling vs AUD
ASX
CSL
CSL
ASX
RIO
Rio Tinto
NYSE
MCD
McDonalds
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved